JPRN-UMIN000000796已完成1 期
Cellular immunotherapy for acute myeloid leukemia using dendritic cells pulsed with WT1 peptide and zoledronate - Cellular immunotherapy for acute myeloid leukemia using dendritic cells pulsed with WT1 peptide and zoledronate
Department of Hematology and Oncology, Kyoto University Hospital0 个研究点目标入组 6 人开始时间: 2007年8月10日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 69years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.There is deep seated active infection 2.There are other malignancies 3.There are leukemic lesions in the central nervous system 4.There is active autoimmune disease 5.Positive for HBs Ag, HCV Ab, HTLV-I Ab, HIV Ab, or serological test for syphilis 6.Responsible doctors judged the patient inappropriate for the trial
研究者
相似试验
已完成
1 期
Cellular immunotherapy for acute myeloid leukemia using dendritic cells that endocytosed autologous leukemic cellsacute myeloid leukemiaJPRN-UMIN000001024Department of Hematology and Oncology, Kyoto University Hospital5
已完成
2 期
Prospective Study of Mylotarg and G-CSF in Acute Myeloid Leukemia TreatmentNovo Acute Myeloid LeukemiaNCT01698879Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias46
进行中（未招募）
不适用
Treatment for acute myeloid leukemia (AML) during its first complete remision with the monoclonal antibody Mylotarg ® (anti-CD33/calicheamicina) pre- and post- autologous transplant of hematopoietic stem cellsAcute myeloid leukemia (AML) during its first complete remision and with high relapse risk, pre- and post- autologous hematopoiteic transplantEUCTR2005-000640-91-ESInstitut de Recerca Hospital Sta. Creu i St. Pau20
已完成
不适用
Risk adapted treatment of Acute Myelocytic Leukaemia (AML)Acute Myeloid Leukaemia (AML)CancerISRCTN76815071Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)1,105
已完成
不适用
Treatment protocol for acute promyelocytic leukemia -FBMTG-APL2009acute promyelocytic leukemiaJPRN-UMIN000001742Fukuoka Blood & Marrow Transplant Group50